Irving WL - Search Results

1

Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.

Llibre A, Shimakawa Y, Mottez E, Ainsworth S, Buivan TP, Firth R, Harrison E, Rosenberg AR, Meritet JF, Fontanet A, Castan P, Madejón A, Laverick M, Glass A, Viana R, Pol S, McClure CP, Irving WL, Miele G, Albert ML, Duffy D. Llibre A, et al. Among authors: irving wl. Gut. 2018 Nov;67(11):2017-2024. doi: 10.1136/gutjnl-2017-315783. Epub 2018 Apr 3. Gut. 2018. PMID: 29615488 Free PMC article. Clinical Trial.

2

Chronic hepatitis in children after liver transplantation: role of hepatitis C virus and hepatitis G virus infections.

Davison SM, Skidmore SJ, Collingham KE, Irving WL, Hubscher SG, Kelly DA. Davison SM, et al. Among authors: irving wl. J Hepatol. 1998 May;28(5):764-70. doi: 10.1016/s0168-8278(98)80225-0. J Hepatol. 1998. PMID: 9625310

3

Hepatitis G virus infection in lymphoma and in blood donors.

Minton J, Iqbal A, Eskiturk A, Irving W, Davies J. Minton J, et al. J Clin Pathol. 1998 Sep;51(9):676-8. doi: 10.1136/jcp.51.9.676. J Clin Pathol. 1998. PMID: 9930072 Free PMC article.

4

Acute hepatitis C virus infection: a neglected disease?

Irving WL. Irving WL. Gut. 2006 Aug;55(8):1075-7. doi: 10.1136/gut.2005.085407. Gut. 2006. PMID: 16849345 Free PMC article. Review.

5

Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes.

Brown RJP, Tarr AW, McClure CP, Juttla VS, Tagiuri N, Irving WL, Ball JK. Brown RJP, et al. Among authors: irving wl. J Gen Virol. 2007 Feb;88(Pt 2):458-469. doi: 10.1099/vir.0.82357-0. J Gen Virol. 2007. PMID: 17251563

6

Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.

Neal KR; Trent Hepatitis C Study Group; Ramsay S, Thomson BJ, Irving WL. Neal KR, et al. Among authors: irving wl. Gut. 2007 Aug;56(8):1098-104. doi: 10.1136/gut.2006.113217. Epub 2007 Mar 7. Gut. 2007. PMID: 17344277 Free PMC article.

7

Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.

Hamed MR, Tarr AW, McClure CP, Ball JK, Hickling TP, Irving WL. Hamed MR, et al. Among authors: irving wl. J Viral Hepat. 2008 May;15(5):339-45. doi: 10.1111/j.1365-2893.2007.00947.x. Epub 2008 Jan 22. J Viral Hepat. 2008. PMID: 18221305

8

Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.

Tarr AW, Urbanowicz RA, Hamed MR, Albecka A, McClure CP, Brown RJ, Irving WL, Dubuisson J, Ball JK. Tarr AW, et al. Among authors: irving wl. J Virol. 2011 May;85(9):4246-57. doi: 10.1128/JVI.01332-10. Epub 2011 Feb 16. J Virol. 2011. PMID: 21325403 Free PMC article.

9

Use of short tandem repeat fingerprinting to validate sample origins in hepatitis C virus molecular epidemiology studies.

Edwards VC, McClure CP, Brown RJP, Thompson E, Irving WL, Ball JK. Edwards VC, et al. Among authors: irving wl. J Gen Virol. 2014 Jan;95(Pt 1):66-70. doi: 10.1099/vir.0.057828-0. Epub 2013 Oct 7. J Gen Virol. 2014. PMID: 24100764 Free PMC article.

10

Predictors of hepatitis C treatment response: what's new?

Berry L, Irving W. Berry L, et al. Expert Rev Anti Infect Ther. 2014 Feb;12(2):183-91. doi: 10.1586/14787210.2014.874283. Epub 2014 Jan 3. Expert Rev Anti Infect Ther. 2014. PMID: 24404996 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters